Speaker illustration

Doctor Felix Wiedmann

University hospital Heidelberg, Heidelberg (Germany)

Member of:

European Society of Cardiology
European Heart Rythm Association

Dr. Felix Wiedmann was born in Germany in 1987. He received the M.D. degree from Heidelberg University in 2014 where he is currently employed as a cardiologist and basic scientist at the Department of Cardiology, University Hospital Heidelberg. His doctoral thesis, focusing on the “Cardiac roll of two pore domain potassium channels” was awarded with the Kaltenbach scholarship of the German Heart Foundation and the Otto-Hess scholarship of the German Cardiac Society. His research interests cover heart rhythm disorders and their underlying mechanisms. In 2016, he was the recipient of the Ludolf-Krehl-Price. In 2019 he was awarded with the Young Investigator Award Basic and Translational Science at the EHRA Congress.

Evaluating the reversibility potential of atrial cardiomyopathy on a clinical and cellular level

Event: ESC Congress 2022

Topic: Pathophysiology and Mechanisms

Session: Insights in the pathophysiology of atrial fibrillation

Thumbnail

S-ICD implantation for secondary prevention in a case of complex congenital heart disease with dextrocardia and situs solitus.

Event: ESC Congress 2022

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Adult congenital heart disease

Thumbnail

The COVID-19 viral 3a protein forms a potassium channel that can be inhibited by antiarrhythmic drugs

Event: EHRA 2022

Topic: Arrhythmias

Session: Young Investigator Award - Basic and Translational Science

Thumbnail

Neuropeptides as novel regulators of human atrial TASK-1 currents

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Ion Channels, Electrophysiology

Session: New Mechanisms Associated with Atrial Fibrillation

Thumbnail

N-glycosylation of TREK-1 /hK2P2.1 two-pore-domain (K2P) potassium channels

Event: ESC CONGRESS 2019

Topic: Ion Channels, Electrophysiology

Session: Electrophysiology and arrhythmias

Thumbnail

Pharmacological inhibition of atrial TASK-1 channels facilitates acute cardioversion of atrial fibrillation in a large animal model

Event: EHRA 2019

Topic: Arrhythmias

Session: Young Investigator Award - Basic and Translational Science

Thumbnail

Identification of the A293 (AVE1231) binding site in the cardiac two-pore-domain potassium channel TASK-1: a common low affinity antiarrhythmic drug binding site

Event: EHRA 2019

Topic: Ion Channels, Electrophysiology

Session: Ion channel (dys)function and regulation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk